Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000). (Q34464990)

2 August 2017

1 reference

title

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000). (English)

1 reference

2 August 2017

0 references

1 reference

Beutels P

1

1 reference

PubMed ID

11747055

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

10

1 reference

2 August 2017

751-774

1 reference

2 August 2017

8

1 reference

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

2 August 2017

1 reference

Is vaccination against hepatitis B efficient? A review of world literature

21 January 2018

1 reference

Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection

21 January 2018

1 reference

The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies

21 January 2018

1 reference

Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations

21 January 2018

1 reference

Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales

21 January 2018

1 reference

Gains in life expectancy from medical interventions--standardizing data on outcomes

21 January 2018

1 reference

Methodological quality of economic modelling studies. A case study with hepatitis B vaccines

21 January 2018

1 reference

The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes

21 January 2018

1 reference

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

21 January 2018

1 reference

Epidemiology of hepatitis B

21 January 2018

2 references

21 January 2018

inferred from DOI database lookup

7 January 2021

based on heuristic

The transmission dynamics and control of hepatitis B virus in The Gambia

1 reference

Vaccination against hepatitis B virus in highly endemic areas: waning vaccine-induced immunity and the need for booster doses

21 January 2018

1 reference

Discounting costs and effects: a reconsideration

21 January 2018

1 reference

Discounting and health benefits

21 January 2018

1 reference

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

21 January 2018

1 reference

An economic evaluation of universal vaccination against hepatitis B virus

21 January 2018

1 reference

Accounting for future costs in medical cost-effectiveness analysis

21 January 2018

1 reference

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

21 January 2018

1 reference

Targeted hepatitis B vaccination--a cost effective immunisation strategy for the UK?

21 January 2018

1 reference

Ante-natal screening for hepatitis B surface antigen: an appraisal of its value in a low prevalence area

21 January 2018

1 reference

An appraisal of the efficacy and cost effectiveness of antenatal screening for hepatitis B.

21 January 2018

1 reference

Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison

21 January 2018

1 reference

Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage

21 January 2018

1 reference

Is the strategy of universal hepatitis B vaccination necessary in low-endemic countries?

21 January 2018

1 reference

Control of hepatitis B in the United Kingdom.

21 January 2018

1 reference

Developed countries could pay for hepatitis B vaccination in developing countries

21 January 2018

1 reference

Are booster immunisations needed for lifelong hepatitis B immunity?

21 January 2018

1 reference

Economic evaluation of various hepatitis B vaccination Strategies in Switzerland

21 January 2018

1 reference

Hepatitis B immunization in a low-incidence province of Canada: comparing alternative strategies

21 January 2018

1 reference

Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness

21 January 2018

1 reference

Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysis

21 January 2018

1 reference

Differences in the methodology and data of economic evaluations of a health programme. The case of hepatitis B vaccination programmes in Spain

21 January 2018

1 reference

Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity

21 January 2018

1 reference

Cost-effectiveness of hepatitis B vaccine in The Gambia.

21 January 2018

1 reference

Economic evaluations applied to HB vaccination: general observations

21 January 2018

1 reference

Status of hepatitis B immunization programmes in 1998

21 January 2018

1 reference

Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study

21 January 2018

1 reference

Hepatitis B immunization strategies: expanding the target

21 January 2018

1 reference

Substantial decline of notified hepatitis B in major parts of Europe after 1985

21 January 2018

1 reference

Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysis

21 January 2018

1 reference

Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program

21 January 2018

1 reference

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

21 January 2018

1 reference

The influence of age on the development of the hepatitis B carrier state

21 January 2018

1 reference

Economic foundations of cost-effectiveness analysis

21 January 2018

1 reference

Theoretical issues in cost-effectiveness analysis

21 January 2018

1 reference

Cost of acute hepatitis B infection in Swedish adults

21 January 2018

1 reference

Why the Scandinavian countries have not implemented universal vaccination against hepatitis B

21 January 2018

1 reference

[Economic evaluation of various hepatitis B vaccination strategies in children and adolescents]

21 January 2018

1 reference

Cost-effectiveness analysis of hepatitis B vaccination strategies in Catalonia, Spain

21 January 2018

1 reference

Hepatitis B immunization programme: Spain

21 January 2018

1 reference

Cost-Effectiveness of Hepatitis-B Vaccine in Greece: A Country of Intermediate HBV Endemicity

21 January 2018

1 reference

Calculating the global burden of disease: time for a strategic reappraisal?

21 January 2018

1 reference

Prevention and control of hepatitis B in central and eastern Europe and the newly independent states, Siofok, Hungary, 6-9 October 1996

21 January 2018

1 reference

Hepatitis B virus eradication strategy for Asia. The Asian Regional Study Group

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEC.625

1 reference

2 August 2017

1 reference

PubMed ID

11747055